Background: Dopamine transporter (DAT) and α-synuclein interact, but the mode and mechanism of α-synuclein regulation of DAT activity are less-known. Results: Elevated intracellular α-synuclein alters DAT-mediated currents and activity that are abrogated by DAT blocker and are absent with heat-inactivated α-synuclein. Conclusion: DAT/α-synuclein interaction at the cell surface alters the ionic coupling of DAT. Significance: This interaction modulates dopamine transmission and thus neuronal function.
Summary
Dysregulation of dopamine (DA) homeostasis is implicated in neurodegenerative diseases, drug addiction, and neuropsychiatric disorders. The neuronal plasma membrane dopamine transporter (DAT) is essential for the maintenance of DA homeostasis in the brain. α-synuclein is a 140-amino acid protein, which forms a stable complex with DAT and is linked to the pathogenesis of neurodegenerative disease. To elucidate the potential functional consequences of DAT/α-synuclein interaction, we explored α-synuclein modulation of DAT activity in midbrain dopaminergic neurons obtained from TH::RFP mice, immortalized DA neurons and a heterologous system expressing DAT. We used dual pipette whole cell patch clamp recording to measure the DAT mediated current before and after dialysis of recombinant α-synuclein into immortalized DA neurons. Our data suggest that intracellular α-synuclein induces a Na The development of effective therapeutic interventions for neurodegeneration requires a better understanding of the early events that precede neuronal loss. Recent work in various disease models has begun to emphasize the significance of presynaptic dysfunction as an early event that occurs before manifestation of neurological disorders (1) (2) (3) (4) (5) (6) (7) (8) (9) . Dysregulation of dopaminergic transmission is strongly implicated in the pathogenesis of drug addiction, schizophrenia, and Parkinson's disease (10-13). Synaptic dopamine (DA) levels are primarily regulated by the dopamine transporter (DAT) (14) , a presynaptic membrane protein that is a member of the Na + /Cl --dependent co-transporter gene family (15, 16) . By removing extracellular DA and recycling it back into the neuron, DAT plays an essential role in the replenishment of synaptic DA and in terminating DA signaling. An increasing number of proteins have been identified that interact with different domains of the dopamine transporter. These interactions suggest that the synaptic distribution and functional properties of DAT can be regulated via interacting proteins. Most of the known DAT-interacting proteins have been identified using the yeast two-hybrid system. The DAT-interacting proteins identified to date using the Y2H system include: protein that interacts with C kinase-1 (PICK1) (17) ; the focal adhesion protein Hic-5 (18); α-synuclein (19) ; receptor for activated C kinase-1 (RACK1); syntaxin (20) ; and CaMKIIα (21, 22) . Although the exact stoichiometry of the interaction is not known, using the yeast two-hybrid system, Lee et al. demonstrated that the dopamine transporter physically interacts with α-synuclein (19), a small synaptic protein (23) (24) (25) that is linked to Parkinson's disease (26) . Formation of a stable complex between α-synuclein and DAT has been further confirmed by coimmunoprecipitation experiments (27, 28) , and also verified in the present study.
Abnormal accumulation of α-synuclein is strongly implicated in Parkinson's disease. For example, massive accumulation of α-synuclein the in substantia nigra of patients with triplication of α-synuclein and in midbrain dopamine neurons of chronic cocaine abusers are reported (29) (30) (31) (32) (33) . Recently, Tong et al., reported that high concentrations of α-synuclein (more that 1700% of control) are found in neurodegenerative disorders such as Parkinson's disease, familial Parkinsonismdementia and multiple system atrophy (33) . Similarly, Mash laboratory reported overexpression of alpha synuclein in dopamine neurons of cocaine abusers (30) . Therefore, the studies reported here focus on the consequence of overexpression of asynuclein.
Unlike findings for α-synuclein knockout mice (5) , it has been shown that dopamine levels in the brains of null mice for both α and β synucleins are decreased by approximately 20% (5) . Mice null for only α-synuclein have a largely normal phenotype (5) . In contrast, increased expression of α-synuclein reduces neurotransmitter release by inhibiting vesicle re-clustering and endocytosis (4), as well as inhibition of catecholamine release from adrenal chromaffin cells (34) . In dopaminergic-like cell lines α-synuclein over-expression increases membrane conductance reminiscent of a leak channel (35) suggesting a physiological role for membrane destined α-synuclein (35) .
The role of α-synuclein in dopaminergic transmission and its underlying mechanism is not fully understood, primarily because data to date appear conflicting. While Lee et al. have shown that α-synuclein overexpression results in DAT clustering at the plasma membrane and increased DAT function (19) , Wersinger and Sidhu have reported a decreased cell surface expression of DAT and inhibition of DAT activity when α-synuclein is over-expressed (27, 28) .
To address these conflicting findings and further explore the functional consequences of DAT/ α-synuclein interaction at the cell surface we utilize single cell dual pipette whole cell patch clamp recordings to measure DAT-mediated current before and after dialysis of recombinant α-synuclein into immortalized DA neurons expressing dopamine transporter. We found that introducing α-synuclein intracellularly induces a Na + independent but Cl -sensitive inward current in immortalized DA neurons and DAT-expressing cells, which is eliminated by the DAT antagonist GBR12935, and is absent when the cell is dialyzed with heat-inactivated α-synuclein. Furthermore, our finding suggests that over-expression of α-synuclein decreases DAT-mediated substrate uptake without decreasing the overall number of transporters at the membrane.
Experimental Procedures
Reagents and drugs were purchased from Sigma (St. Louis, MO) unless otherwise noted. α-synuclein was purchased from Millipore (Temecula, CA). α-synuclein cDNA plasmid was a generous gift from Dr. Ted M. Dawson, Johns Hopkins School of Medicine.
Primary neuronal culture of acutely dissociated TH::RFP mouse midbrain dopamine neurons: All animals were treated in accordance with NIH and ARVO guidelines. Mouse midbrain neuronal cultures were obtained from a transgenic mouse strain generated as described previously (36) . Briefly, the tyrosine hydroxylase promoterdriven red fluorescent protein transgene (TH::RFP) was constructed by ligating a 4.5 kb HindIII/EcoRI fragment of the rat tyrosine hydroxylase promoter with DsRed2-1 (Clontech, Palo Alto, CA). The acutely dissociated mouse midbrain dopaminergic neurons from 1-3 days old pups were isolated and grown on a monolayer of glial cells on Poly-D lysine treated glass bottom dishes as we have described previously (21, 37) . These neurons were used for the electrophysiology recordings according to our previous reports (21, 37) .
Immortalized DA neuronal culture, cell lines and cell culture-Immortalized DA neurons: The immortalized DA neurons 1RB3AN27 cells or 1RB3AN27 cells overexpressing human DAT used in this study were gifts from Dr. Haley Melikian (University of Massachusetts) and have been characterized previously (38) (39) (40) (41) (42) (43) . The immortalized DA neurons were originally derived from fetal rat mesencephalon, and were characterized and tested in 6-hydroxydopamine (6-OHDA)-lesioned rats by Curt Freed's laboratory (38) . Cells double every 26 h, which upon differentiation contain tyrosine hydroxylase and DAT proteins and their respective mRNAs. If untreated, the undifferentiated neurons only have the potential to express DAT. For electrophysiology, experiments we used undifferentiated immortalized DA neurons (1RB3AN27 cells), and undifferentiated immortalized DA neurons over-expressing human DAT. Immunocytochemistry experiments have confirmed previous reports that undifferentiated immortalized DA neurons do not express DAT, unless they are engineered to over-express DAT (data not shown). Cells were grown in RPMI medium supplemented with 5% glutamine, 10% fetal bovine serum at 37 °C, and 5% CO2. To keep the DAT expressing cells under selection 1µL/mL G14 was added to the media. CHO cell line: For imaging experiments, where we needed a fluorophore-transporter fusion protein to track the transporter in real time, we used parental or stably over expressing YFP-DAT CHO cell lines. The CHO cell lines were gifts from Dr. Jonathan Javitch (Colombia University). Previous studies have shown that these cells are flat, have minimal basal fluorescence, and are suitable for image analysis (39) . The cells were grown in F12 medium supplemented with 10% fetal bovine serum, 5% glutamine at 37 °C and 5% CO2, and 1.5 µL/mL hygromycin.
Subcloning of α-synuclein into eCFP-expression vector-The cDNA encoding α-synuclein was subcloned into enhanced cerulean fluorescent protein (eCFP)-expression vector (generous gift from Dr. David Piston, Vanderbilt University). Using PCR and are GGTGAACTTTCATGGATGT ATTCATGAAAGGA (upstream) and GCGT CTAGAGGCTTCAGGTTCGTAGTC (downstream). The PCR product was digested with HindIII and XbaI and ligated into multiple cloning sites of pRC/CMV vector. The ligation product was transformed into E-Coli strain DH5alpha, the cDNA was purified, and successfully subcloned. cDNA was purified in large scale using Maxi-prep kit (Qiagen, Valencia, CA). Sequencing confirmed the product obtained was α-synuclein.
Western Blot analysis-Western blot analyses were performed as described previously (21, 33) . In brief, YFP-DAT-CHO cells, IRBN27-DAT cells or midbrain samples were washed with ice-cold 0.1 M PBS, homogenized in lysis buffer (0.01 M TrisHCl, pH 7.6, 0.1 M NaCl, 0.001 M EDTA, 100 µg/ml PMSF and 1 µg/ml aprotinin) and then centrifuged at 15000× g for 30 min. Protein concentrations were determined using the BioRad D c Protein assay (BioRad, Temecula, CA). Twenty µg of total protein was electrophoresed on 10% SDSpolyacrylamide gels and then transferred to Hybond-P™ membranes (GE Healthcare, Piscataway, NJ) as described previously (21, 33 Patch electrodes were pulled from quartz pipettes on a P-2000 puller (Sutter Instruments, Novato, CA) and filled with the pipette solution. Whole cell currents were recorded using an Axopatch 200B (Molecular Devices, Sunnyvale, CA) with a low-pass Bessel filter set at 1,000 Hz. Current-voltage relations were generated using a voltage step (500 msec) protocol ranging from -100 to +60 mV separated by 20 mV from a holding potential of -20 mV. Data were recorded and analyzed off-line using pCLAMP9 software (Molecular Devices, Sunnyvale, CA).
We used a technique we term "dual whole cell patch clamp" electrophysiology, a modification of a recording configuration used by Mazzanti et al. (44, 45) to determine the effect of α-synuclein on DAT-mediated whole cell currents in immortalized DA neurons stably over-expressing DAT. The "dual whole cell patch clamp" electrophysiology was performed as follows: one electrode is designated as the recording electrode and the 2 nd electrode is designated as the dialysis electrode, 1) Two gigaohm seals are acquired with two electrodes on the same cell. 2) Whole cell voltage clamp mode is achieved in the "recording" electrode and 10 minutes later an I(V) curve is measured, 3) Whole cell current clamp is achieved in the "dialysis" electrode. We briefly placed the recording electrode in current clamp mode while the membrane test voltage verified break-in of the dialysis electrode. Once the dialysis electrode has achieved whole cell configuration, it is placed in current clamp mode, and the recording electrode is returned to voltage clamp mode. Our laboratory and other laboratories have demonstrated that maximum dialysis occurs within 8-10 min after establishing the whole cell configuration (46) (47) (48) . The cell is thereby dialyzed with the contents of the dialysis electrode for 10 minutes followed by an I(V) recording (Fig 1) (using command potentials generated by the voltage clamp recording electrode). As a control, the voltage of the dialysis electrode was monitored to assure the recording electrode had a tight voltage clamp throughout the experiment. The dual whole cell technique was performed with the recording and dialysis electrodes both containing internal solution (37, (46) (47) (48) , as described (Fig 1) , or the recording electrode filled with internal solution and the dialysis electrode containing internal solution +5 μM α-synuclein or heat inactivated α-synuclein (Fig 2) . The dual whole cell experimental configuration permits measurement of I(V) before and after α-synuclein dialysis. The external solution contained either external solution or contained an iso-osmotic ion substitution when ion substitution strategies were conducted. In this document, consistent with electrophysiological nomenclature, an "inward" current refers to an ionic event that requires the clamp electrode to pass negative current into the cell to keep the voltage clamped at a given potential. As such, the term "inward" in this context does not refer to the direction of the ion flow, hence, the flow of positive ions into the cell and/or flow of negative ions out of the cell both produce an "inward" current.
In this study the DAT-dependent current is defined as currents we measure, based on our previous studies (46) (47) (48) , that are blocked by DAT blockers, like GBR12935.
Selection of the 5 micromolar concentration of alpha-synuclein for use in our recording pipette-We used quantitative or semi-quantitative neurochemical measurements of the full-length 19 kDa α-synuclein that was extrapolated against a standard curve calibrated by using 1) purified recombinant α-synuclein, 2) cells overexpressing α-synuclein, 3) α-synuclein levels in the midbrain region of animals treated with neurotoxic does of methamphetamine (an animal model of system atrophy) (unpublished data, Gamble-George and Khoshbouei). These criteria suggest that 5 micromolar recombinant α-synuclein (0.07 µg of recombinant human α-synuclein) can be detected as a 19 kDa protein (supplemental Fig 2) and is in the median range of our quantitative or semiquantitative neurochemical measurements. Therefore, in a reduced system such as ours, 5micromolar α-synuclein in the recording pipette may actually be an underestimation of actual increase in α-synuclein levels reported in synucleinopathies (see introduction), (29) (30) (31) (32) (33) .
Measurement of DAT activity using ASP + , a fluorescent substrate of DAT-The experiments were performed as previously described (49- (37, 47, 48, 54, 55) . The cells were washed 2X with external solution with a final pH of 7.35 and osmolarity of 290 mOsm as described above. One ml of external solution was added to the dish and cells were selected for imaging with a Nikon inverted TE2000-U C1 laser scanning confocal microscope (Nikon, Melville, NY). A 40x 1.3 NA Plan-fluor objective (Nikon) was used with the confocal pinhole set to one Airy unit. Pilot experiments at both room temperature and 37° were performed-the relative difference between experimental conditions was unchanged regardless of temperature (data not shown), however, to be comparable to the preponderance of the ASP + literature (51) (52) (53) 56, 57) and electrophysiology data in this study aa well as others (21, 37, (58) (59) (60) (61) (62) (63) , we chose to perform our experiments at room temperature. The cells were selected with the appropriate filter sets. The CFP-α-synuclein was identified using a CFP specific filter set, and YFP-DAT was identified using a YFP filter set. For analysis purposes at the start of each experiment 512x512 pixel reference images showing cells expressing YFP-DAT alone, cells co-expressing CFP-α-synuclein/YFP-DAT, cell expressing CFP-α-synuclein alone or cells expressing neither protein were saved and labeled for analysis.
This provides an internal experimental control-because not every cell co-expresses both proteins. Using this approach, real time quantification of DAT-mediated substrate uptake in single cells was measured using the high-affinity, fluorescent DAT substrate ASP + (51, 56, 57) . The sampling frequency was 1.52 fps, over 8 minutes that provided 692 images. After 10 baseline images, ASP + was added to a final concentration as noted in the result section (Fig 5, 6 ). ASP competition experiments, the data were fit with GraphPad Software Prism 5.0, using the least squares method to fit a regression line (at t=75-250 sec). (Fig 6A) . Data were analyzed for rejection of the null hypothesis using a one-way ANOVA followed by a Bonferroni post-hoc test (Figs 5, 6 ; supplemental tables 1,2). Tests were performed using Prism version 5.0 statistical software package (GraphPad Software). A value of p < 0.05 was considered statistically significant. F values, degrees of freedom, and significance are also documented in supplemental figures.
Results
Dual patch clamp recording does not affect DAT-mediated whole cell currents and DAT reversal potential. Formation of a stable complex between α-synuclein and DAT has been further confirmed by coimmunoprecipitation experiments (27, 28) , and also verified in the present study ( Supplemental Fig 1) . To determine the regulatory role of α-synuclein on DATmediated whole cell currents in immortalized DA neurons stably over-expressing DAT, we used dual patch clamp electrophysiology (44, 45) . Conventional whole cell patch clamp can measure DAT-related activity by using a single patch electrode for both dialysis of internal solution and recording; a technique that has been used successfully by us and other groups (37, 46, 48) . In this study, to effectively determine the regulatory role of α-synuclein on the electrogenic properties of DAT, we used a dual patch clamp recording technique that provides measurement of DATmediated currents in the presence or absence of intracellular α-synuclein in the same cell. We measured DAT-mediated currents when physiological-like internal solution, α-synuclein, or heat inactivated α-synuclein were dialyzed into the cell as described in the Materials and Methods section. The currentvoltage I(V) relationships when both recording and dialysis electrodes filled with physiological-like solution were examined when the membrane potential was stepped from +60 mV to -100 mV in 20 mV increments-generated after single and double whole cell configurations (Fig 1) . These current-voltage I(V) relationships were virtually overlapping (Fig 1) . The amplitude of DAT-mediated currents at -100 and the reversal potentials measured under these conditions were: for the whole cells currents, -22.2 + 7.27 pA (single) and -19.3 + 6.9 pA (double); and for the reversal potential, -35.4 + 2.1 mV (single), -33.73 + 1.8 mV (double), respectively (n=7). These values are little changed from single to double whole cell configuration, and are consistent with reported DAT-mediated currents in the literature (37, 46, 48, 62, 63) . These findings suggest that our dual patch clamp recording strategy is a viable approach for determining whether α-synuclein regulates DAT-mediated currents.
α-synuclein increases DAT-mediated inward currents and induces a rightward shift in the DAT-mediated current-voltage I(V) relationship. DAT-mediated currents are ion-and voltage-dependent (58, 59, 62, 63) , and that can potentially affect the membrane microenvironment near the transporter, and the activity of other targets (61, 62) . To determine whether α-synuclein regulates DAT-mediated currents, we introduced 5 µM recombinant α-synuclein or 5 µM heat inactivated α-synuclein (Fig 2) into the dialysis electrode. Dialysis of α-synuclein into the cell increased the inward currents at membrane potentials close to and below the resting membrane potential, but had minimal effect on the electrogenic properties of DAT at potentials above -20 mV. Compared to the absence of α-synuclein, the intracellular α-synuclein increased the magnitude of currents at -80 mV and -100 mV about 3.9 and 3.3 fold, respectively when the I(V) plot is normalized (Fig 2 and supplemental Fig 3 showing the normalized I(V) plot). In contrast, intracellular α-synuclein had minimal effect on DAT-mediated currents at potentials above -20 mV. Overall, α-synuclein-stimulated currents produced a net depolarizing effect on the DAT reversal potential, causing a ~ 20.6 mV right ward shift (from -33.7 + 2.7 mV to -17.6 + 3.07 mV) in the reversal potential (Fig  2A) . Using Goldman-Hodgkin-Katz Equation, when R= 8. (Fig 2C) .
In parallel experiments we found that over-expression of α-synuclein depolarizes DAT cells, and that this depolarized state of the cell is a consequence of α-synuclein expression. As shown in Fig 2B, 
Dialysis of heat-inactivated α-synuclein (5 µM, 10 min 70 o C) did not affect the magnitude of the inward currents or the reversal potential (Fig 2D) . Therefore, it appears that intracellular α-synuclein might have a direct or indirect effect on ionic permeability of DAT-associated inward current.
The dialysis of α-synuclein (5 µM), via the recording electrode, into DA neuron obtained from acutely dissociated midbrain region of TH::RFP mice also produce an increase in inward currents at -60, -80 and -100 mV membrane potentials (Fig 3) . Therefore, our result is consistent with the interpretation that the impact of α-synuclein overexpression on DAT activity (i.e. DATmediated DA uptake (see below)) is independent of cellular background, such that α-synuclein overexpression increases DATmeditated inward currents and decreases DAT-mediated DA uptake in cell types studied.
Endogenous physiological levels of α-synuclein have no detectable effect on DAT-mediated currents. α-synuclein expression in mouse midbrain, 1RB3AN27-DAT and YFP-DAT-CHO cells was examined by Western immunoblot analysis as described in the Methods section and compared with dilutional standards of recombinant α-synuclein ( Supplemental Fig 2A, B, C) . The Western blot analysis suggests that, unlike native midbrain neurons, the undifferentiated 1RB3AN27-DAT and YFP-DAT-CHO cells do not express α-synuclein (Supplemental Fig  2C) . It is also possible that the expression level of α-synuclein in these cells is below our detection limit).
To test whether endogenous physiological levels of α-synuclein influence the dopamine transporter-induced inward currents, we determined DAT-mediated inward current in whole cell configuration in DA neurons (which express endogenous physiological levels of α-synuclein) compared to undifferentiated 1RB3AN27-DAT and YFP-DAT-CHO cells (which lack α-synuclein). Consistent with the previous reports, we found no significant difference in DAT-mediated inward currents in DA neurons and DAT-expressing heterologous cells lacking endogenous α-synuclein expression (Supplemental Fig 2C, D) (37, 47, 48) . Taken together our findings are consistent with the interpretation that the endogenous levels of α-synuclein may not influence the activity of DAT in a measurable level, but it is the overexpression of α-synuclein that alters the activity of dopamine transporter.
α-synuclein-stimulated inward currents do not require extracellular Na + ions. Currents identified for DAT are Na + /Cl -dependent and they include 1) a transport current reflecting substrate movement, and 2) an uncoupled current that can be blocked by DATinhibitors. Inward currents in voltage clamp mode are mediated by positive ions entering the cell and/or inward ions leaving the cell. Since intracellular α-synucleinmodulated an inward current in the absence of substrate, we hypothesized that α-synucleinmodulated currents are caused either by an increase in inward movement of Na + , or outward movement of Cl -. We used ion substitution strategies to examine this hypothesis. With the iso-osmotic substitution of CholineCl for NaCl in the external solution, in the presence of intracellular α-synuclein (5 µM), the inward currents were still 3-4 fold larger than the currents measured in the absence of α-synuclein (4.2 + 1.4 at -100 mV) (n=4; Fig 4A) The calculated ECl in this condition is ~ +8 mV. Under these conditions, there is an additional increase in α-synuclein-modulated inward currents compared to control solutions (Fig 4B, n=5) . These findings suggest that α-synuclein may directly or indirectly affect the transport-associated currents by increasing outward Cl -transport. α-synuclein decreases DATmediated substrate uptake. To determine the consequences of α-synuclein/DAT interaction on the activity of DAT, we used a fluorescent tool, ASP + , (49) (50) (51) (52) (53) that allows quantitative measurement of substrate uptake into DATexpressing cells, with msec time resolution at the single cell level in the presence and absence of intracellular α-synuclein. Consistent with previous reports, we found that ASP + rapidly binds at the membrane and is transported into DAT expressing cells (49) (50) (51) (52) (53) . Fluorescent DAT substrate ASP+ was added to cells that expressed either YFP-DAT (Fig 5A, left panel) or YFP-DAT and CFP-α-synuclein (Fig 5A, middle panel, merge right  panel) . The ASP+ uptake was quantified as changes in fluorescence levels in the cytoplasm of DAT expressing cells + α-synuclein compared to baseline measure. The background signal is defined as non specific fluorescence levels of cells not expressing YFP-DAT, and is subtracted. The DATmediated ASP+ binding and transport were characterized by a rapid (in milliseconds) binding phase, where ASP+ fluorescence accumulated at the cell membrane and an uptake phase, where ASP+ signal increased in the cell cytoplasm (Fig 5B) . The accumulation of ASP + into the DAT-expressing cells increased linearly in a time-dependent fashion. The rate of ASP + uptake was quantified by linear regression of the data between 75 and 250 seconds, fit by least squares regression to a straight line between those time points (minimum r-squared > 0.95). Compared to DAT cells, the cells that expressed both α-synuclein and DAT had a decreased rate of ASP + uptake (Fig 5C, D uptake, in both DAT and DAT/α-synuclein cells; nonetheless, the rate of ASP + uptake was lower in DAT/α-synuclein cells. The total DAT protein levels (supplemental Fig 1) and the maximum initial ASP + binding was not different between the two groups ( Fig  5C) .
In the competition experiments, extracellular DA decreased the uptake of ASP + in a concentration-dependent fashion (Fig 6B) , confirming that DA and ASP + uptake occur via similar pathway. The presence of α-synuclein in cells in these experiments also resulted in decreased ASP + uptake (Fig 6A, B) . The log[DA] vs. slopes in the competition experiments were non-linear fit by the least squares method (Fig 6B) , with a calculated IC 50 of 1.2 µM. Intracellular α-synuclein increased the IC50 to 2.9 µM (Fig  6B, supplemental table 2) .
Unlike the rate of ASP (Fig 5C) . These findings suggest that α-synuclein decreases the uptake rate of the substrate via DAT by decreasing the activity, but not levels of the transporter at the plasma membrane.
Discussion
Regulation of DAT activity plays a key role in extracellular dopamine availability. The findings that DAT interacts with α-synuclein (19, 27, 28) , a protein implicated in neurodegenerative disease, provoked our interest in functional consequence of this interaction on DAT activity. High concentrations of α-synuclein (more that 1700% of control level) are found in neurodegenerative disorders such as Parkinson's disease, familial Parkinsonism-dementia and multiple system atrophy (33) . Using the single cell, dual patch clamp approach, we were able to focus on the impact of α-synuclein on DAT activity in real time. We found that intracellular α-synuclein induces a DAT-mediated inward current that is independent of extracellular Na + , but sensitive to the transmembrane Cl -gradient. This inward current is eliminated by DAT antagonist GBR12935, and is absent with intracellular heat-inactivated α-synuclein. Intracellular α-synuclein mediates a rightward shift in the DAT reversal potential and depolarizes the membrane. These changes are paralleled by α-synuclein-dependent decrease in rate of DAT-mediated substrate uptake.
Our studies directly assess the effect of α-synuclein on DAT activity when α-synuclein is dialyzed into DA neuron (21, 37) or immortalized mesencephalic neuronal cells (IRB3AN27) stably over-express human dopamine transporter (38, 39, 64) via the patch clamp electrode or when α-synuclein is transiently over-expressed. Dialysis of α-synuclein into the cell via the patch clamp electrode allows real time assessment of DAT activity before and after intracellular α-synuclein, under identical conditions, and importantly in the same cell. Therefore, it provides a unique experimental configuration that can assess the influence of intracellular α-synuclein on the activity of the transporter in a voltage controlled condition.
DAT associated currents are reported to arise from the stoichiometric coupling of two Na + ions transported and one Cl -ion counter-transported to each molecule of substrate transported (63, 65) . However, Sonders et al., have shown that DAT-mediated currents can occur in the absence of the substrate and are larger than the predicate stoichiometry of the transport cycle (63) . Therefore, it is postulated that DATassociated current can be characterized as both coupled and uncoupled currents via both channel and transporter modes of DAT operations (58, 59, 63) . Consistent with the literature, we found that dialysis of α-synuclein into the cell via the patch clamp electrode results in a DAT-mediated uncoupled inward current that is eliminated by DAT blocker GBR12935. Intracellular α-synuclein mediates a rightward shift in the DAT reversal potential that may be attributed to increases in the inward flow of Na + and/or outward flow of Cl -ions (see below). Consistently with this observation, we found that the membrane potential of DAT cells over-expressing α-synuclein rest at more depolarized membrane potentials (Fig 2) .
We are not the first group to report an increase in the DAT-mediated uncoupled currents (46, (61) (62) (63) . Similar to the effect of α-synuclein on DAT associated inward currents in the absence of the substrate, Ingram et al. previously observed that in the absence of extracellular DA, arachidonic acid (10-100 µM) stimulates a cocaine (DAT blocker)-sensitive, DAT-associated inward current that is 50 fold greater than the inward current normally measured in DAT expressing oocytes (61) .
We also observe that α-synuclein overexpression depolarizes the membrane potentials from -36.5 + 5.5 mV in DAT cells, -20.3 + 3.2 mV in DAT/α-synuclein cells, (p < 0.05) (Fig 2B) . This α-synuclein-regulated change in the resting membrane potential can affect both the excitability of the cell and its energy expenditure. Thus, α-synuclein interaction with DAT may affect neuronal energy consumption that could lead to disruption of cell homeostasis. Since α-synuclein is implicated in neurodegenerative diseases, examination of metabolic cost of α-synuclein over-expression in dopamine neurons is of interest.
One of our goals in this study was to possibly shed some light on the conflicting data concerning the functional consequences of DAT/α-synuclein interaction. Our data is consistent with previous reports by Wersinger et al. that α-synuclein over-expression decreases DA uptake, using 3 [H]DA uptake into cell populations expressing + α-synuclein (27,28). We do not know why Lee et al., also examining 3 [H]DA uptake in cell populations, see increase in DA when α-synuclein is overexpressed (19) . However, in neither of these 3 [H]DA uptake studies it was possible to visualize DAT at the cell surface, or measure live cell, instantaneous (msec) rate of substrate at the single cell level. It is possible that the impact of α-synuclein on DATmediated DA efflux, DAT trafficking or other events that are asynchronous in their multi cell studies limit the interpretation of steady state measurement of 3 [H]DA uptake in the cell population studies.
The magnitude and rate of dopamine uptake and dopamine efflux is determined not only by the number of transporters at the surface membrane but also by the conformational state of the transporters: inward facing conformation vs. outward facing conformation. These conformational states can be regulated by membrane potential (48), intracellular ions (48, 60, 63) , the phosphorylation state of the transporter (47) and membrane cholesterol levels (66). Since we found that total DAT protein (supplemental Fig 1) and the maximum initial ASP + binding between the two groups, DAT cells and DAT + α-synuclein cells, were similar (Fig 5C) , our data provide yet another level of molecular detail for the impact of α-synuclein on DAT function, and are consistent with the interpretation that α-synuclein alters the ionic coupling of DAT to decrease DATmediated substrate uptake without any change in the surface expression of DAT.
The dopamine transporter has been shown to affect membrane excitability (62) , by inducing an inward Na and Cl currents (48, 62, 63) . The α-synuclein-mediated increase in DAT-mediated inward currents can be a consequence of the direct interactions between these two proteins or secondary to formation of conductive pores (67) a result of pathological levels of α-synuclein inside the neuron. These membrane pores can influence membrane conductance (35, 68 ), which in turn can impact DAT properties. The data presented in this study cannot exclude these possibilities. However, the studies do affirm the importance of DAT in the changes in currents observed when α-synuclein is overexpressed, since these currents are not detected in the absence of DAT, when the transporter is blocked by an antagonist, or when heat inactivated rather than native α-synuclein is introduced into the recording pipette.
The variety of ways in which α-synuclein expressed at normal endogenous levels regulates DAT activities is still being clarified. For example, α-synuclein may function as a co-chaperone, as transgenic expression of α-synuclein abolishes the lethality and neurodegeneration caused by deletion of the synaptic vesicle chaperone, cysteine-string protein-α (5,69). In addition, α-synuclein also has been suggested to be involved in intracellular trafficking, since overexpression of α-synuclein in Drosophila and yeast disrupts cargo trafficking within the ER (70, 71) . Interestingly, mice null for α-synuclein show no immediate phenotype (5), though studies in the context of various stressors in these mice have yet to be performed. Nonetheless, the distinctive neuropathology found in hereditary Parkinsonism and dementia is linked to α-synuclein over-expression (72). Thus, our studies are important in revealing the molecular consequences of this increased α-synuclein expression.
Overall, however, our findings provide evidence that interaction of α-synuclein and surface DAT regulates the activity of the transporter that can modulate the synaptic availability of DA in addition to dramatically affecting the membrane microenvironment near the transporter, which may alter homeostasis of DA neurons. Together, these changes would alter multiple properties of DA terminals. The functional consequences of these biophysical changes to in vivo physiology and pathology are yet to be discovered.
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We thank Drs. Lee Limbird and Jonathan Javitch for their helpful suggestions and critical review of this manuscript. This work was supported by National Institutes of Health DA026947, DA021471, and NS071122. Microscopy experiments were performed using the MMC Morphology Core, which is supported in part by NIH grants U01NS041071, U54RR026140, and S10RR0254970. . B) Representative DAT-mediated whole cell currents after single and dual patch clamp showing dual patch clamp does not affect DAT mediated currents. After obtaining two tight seals, the recording electrode was switched into whole cell voltage clamp configuration while the dialysis electrode was kept in current-clamp mode. After a 10 min equilibration period whole cell currents were recorded by stepping the membrane potential in 20 mV steps (+60 to -100 mV), from a holding potential of -20 mV. The dialysis electrode was then gently transitioned into the whole cell configuration, and quickly switched back to current-clamp mode. This electrode remained in current clamp mode throughout the rest of the experiment. Ten minutes after the dialysis electrode assumed whole cell configuration, a 2 nd I(V) was generated. Both electrodes contained physiological-like internal solution (see above) (n=7) .   Fig 2 A,B. α-synuclein increases DAT-mediated inward currents and induces a rightward shift in the current-voltage I(V) relationship. A) The experiments performed as in Fig 1 except the dialysis electrode contained 5 µM α-synuclein. Briefly, after two tight seals were obtained, the recording electrode was transitioned into whole cell configuration. The whole cell currents were recorded as described in Fig 1. The dialysis electrode containing 5 µM α-synuclein was then switched to whole cell configuration, dialyzing the recombinant α-synuclein into the cell for 10 min. Whole cell currents were recorded at this time. (n=4-5). B) Resting membrane potentials of cells expressing DAT only or DAT + α-synuclein (n=6). Fig 2C. Active dopamine transporter is required for α-synuclein stimulated increase in inward currents. A five minute pre-application of a DAT blocker, GBR 12935 (5 µM), eliminates the effect of α-synuclein on inward currents, and the right-ward shift in the current voltage relationship. The black squares represent GBR12935 subtracted baseline currents. The circles represents the currents after the dialysis of α-synuclein into the cell when the transporter is blocked (n=4). Fig  2D. Heat-inactivated α-synuclein does not increase the inward currents, or affect the reversal potential. Averaged normalized whole cell currents before and after dialysis of heatinactivated α-synuclein into the cell; experiments performed as in Figs 2 and 3. Whole cell currents were recorded before and 10 min after dialysis of heat-inactivated α-synuclein into the cell. There is no effect on the reversal potential of the I(V) curve with intracellular heatinactivated α-synuclein (n=4) .   Fig 3 A, B by iso-osmotic substitution of NaCl with Na-acetate. In all experiments the pH for the intracellular and extracellular solutions were adjusted to 7.35. The osmolarity for internal and external solutions kept constant 270 and 290 mOsm respectively. The dialysis pipette contained α-synuclein, or heat inactivated α-synuclein (n= 5). Formation of a stable complex between α-synuclein and DAT has been further confirmed by co-immunoprecipitation experiments [27] [28] , and also verified in the present study. Note that total DAT levels do not change in the presence or absence of α-synuclein. 
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